Cefdinir
- Product NDC
- 67877-524
- 11-digit product format
- 678770524
- Labeler code
- 67877
- Product ID
- 67877-524_ed161b31-baa3-458b-a83b-fe301ad5c455
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Cefdinir
- Dosage form
- CAPSULE
- Route
- ORAL
- Labeler
- Ascend Laboratories, LLC
- Application
- ANDA210220
- Marketing category
- ANDA
- Marketing start
- 2021-02-20
- Marketing end
- 0000-00-00
- Substance
- CEFDINIR
- Active strength
- 300 mg/1
- Pharmacologic classes
- Cephalosporin Antibacterial [EPC],Cephalosporins [CS]
- NDC exclude flag
- No
- Listing certified through
- 2022-12-31
- Current FDA listing
- Historical FDA.report record
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Units | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 67877-524-01 | 67877052401 | 100 CAPSULE in 1 BOTTLE (67877-524-01) | 100 capsule | 2021-02-20 | 0000-00-00 | No | No | Current |
| 67877-524-38 | 67877052438 | 10 BLISTER PACK in 1 CARTON (67877-524-38) > 10 CAPSULE in 1 BLISTER PACK (67877-524-33) | 10 blister pack | 2021-02-20 | 0000-00-00 | No | No | Current |
| 67877-524-60 | 67877052460 | 60 CAPSULE in 1 BOTTLE (67877-524-60) | 60 capsule | 2021-02-20 | 0000-00-00 | No | No | Current |